News and Announcements
DomaCom Finalises First Global Agriculture Crowdfunding Deal
- Published March 14, 2017 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
Crowd-funder DomaCom (ASX:DCL) has signed off on its first foray into agricultural assets with a ground-breaking deal that gives 90 retail investors a stake in a property in Victoria’s prime Western Districts pastoral land.
KEY TAKEAWAYS:
- The 150-hectare property, “Doyles”, which is just outside Casterton near the South Australian border.
DomaCom’s head of property Mr Jason Bennett said that: “The identification of good operators to work with in the leasing of the property was key to the transaction. We are striving to deliver a packaged opportunity to investors to enable them to invest into the rural sector through our platform.”
It is expected that investors will receive an estimated combined income and capital return of 10% per annum on their investment, based on historic returns, which is a significant improvement on bank interest. More importantly they will have the ability to participate in the strong capital growth currently being experienced in the rural sector.
DomaCom CEO Arthur Naoumidis says the group is “enormously proud” to sign off on its first agriculture crowdfunding project, which has taken about two months to bed down.
“It’s our understanding that this is the first crowdfunding project for agriculture assets anywhere in the world. We knew from the Kidman bid that there was a thirst by ‘mum-and-dad’ investors to acquire agriculture assets, and we have been looking at other properties for quite some time.
“People are motivated by a desire to keep prime rural land in Australian hands, as well as the opportunity for steady yield and capital gain. We have already more investors on our books looking to invest in this asset class, so we are confident that the Doyles deal is just the first of many.”
Company Updates
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
The Light Fantastic: Why Invion’s Photodynamic Therapy May Be Attracting Big Pharma’s Attention
Invion Limited is challenging the status quo in oncology with its Photosoft™ platform, a precision therapy that uses light-activated molecules to selectively target cancer cells. By transforming the body’s own immune response and addressing the high costs of current cancer treatments, Invion is positioning itself as a transformative player in the biotech sector. With clinical trials underway and strong institutional partnerships, the company is bridging the gap between scientific breakthrough and accessible, scalable patient care.
From Outback to Boardroom: How SWAN Systems is Codifying Water Stewardship
From the arid deserts of Australia to the boardrooms of global tech giants, SWAN Systems is redefining water efficiency. By bridging the gap between field-level agronomics and autonomous irrigation control, the company is proving that “water-positive” targets can be met with science, data, and a 10x ROI commitment.
Backed By Leading Investment Groups and Family Offices
